Business Wire

EASE Appoints Dr. Kanyinsola Oyeyinka as CEO, Driving Medical Equipment-as-a-Service in Africa

Share

EASE Holdings BV has promoted Dr. Kanyinsola Oyeyinka to Chief Executive Officer to succeed Imraan Soomra, who will, effective May 1, take on a new role as Non-Executive Director of EASE South Africa, the group’s most advanced unit.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423749021/en/

Dr. Kanyinsola Oyeyinka speaks at a healthcare event in Rustenburg, South Africa, in January 2025, where she shared insights from EASE’s growing footprint across the continent.

The appointments come as EASE accelerates the rollout of its Equipment-as-a-Service model, which enables clinics and hospitals to access state-of-the-art PET-CT and MRI scanners, surgical robots, and other high-value machines without significant capital outlay by paying on a per-scan or per-event basis to align their costs with revenue. EASE South Africa is set to lead the rapid expansion of the service after announcing an agreement this month for Standard Bank to provide debt funding for future installations.

Dr. Oyeyinka, who previously served in the UK National Health Service as a medical doctor and had senior roles at the World Bank and the Nigeria Sovereign Investment Authority, has worked across the full healthcare value chain from frontline clinical care to building sustainable diagnostic and oncology platforms and shaping systems-level health reforms. During her three years as Senior Vice President at EASE, Dr. Oyeyinka has led operations in South Africa and Ghana, and driven strategic cross-border scaling with a clear vision for delivering world-class medical technology across Africa and other emerging markets.

“It is thanks to the coordinated leadership between Imraan and Kanyinsola that EASE has built a solid foundation, secured commercial debt funding, and grown our installed base through trusted partnerships,” said Frans van Schaik, Chairman of EASE. “Through her vast experience and commitment, Kanyinsola brings continuity, clarity and passion in taking over the mantle from Imraan, who remains central to driving the biggest component of the EASE network in South Africa.”

EASE’s equipment-as-a-service model has been proven with several installations in recent months. Commissioning of a PET-CT scanner at the Precision Nuclear Oncology and Theranostics facility (PNOAT) in Rustenburg, South Africa, earlier this year followed the deployment of a da Vinci surgical robot in KwaZulu-Natal, South Africa, and an advanced MRI diagnostic imaging system in Akwatia, Ghana.

Without the burden of heavy upfront equipment costs, a longstanding barrier for many healthcare centres in accessing the latest technology, capital is freed up for priorities such as increasing hospital beds and nursing staff. A first-of-its-kind for Africa, this initiative is set to change the healthcare landscape for many hospitals and clinics.

“EASE is more than a business; it’s a platform to rethink how healthcare infrastructure is delivered, financed, and sustained,” Dr. Oyeyinka said. “I’m proud to lead an organisation that is empowering hospitals and clinics to be more deliberate in their use of limited resources to better serve patients.”

The culmination of long-term strategic planning, EASE’s leadership transition ensures that the company enters its next chapter with both stability and momentum. The role draws on the full spectrum of Dr. Oyeyinka’s experience, having served as a doctor, a health financing consultant, a healthcare investment adviser and a member of EASE’s management team.

“Dr. Oyeyinka truly embodies our mission and has been central to our journey to this point,” said Imraan Soomra. “I look forward to continuing our work together with Dr. Oyeyinka at the helm developing EASE in its next international growth phase.”

About EASE

Equipment-as-a-Service (EASE®) is a pay-per-use program that provides businesses and organisations with cost-effective access to state-of-the-art healthcare equipment – and maintenance, training and support – with terms that match their circumstances and business needs. EASE South Africa is a subsidiary of EASE Holdings BV which is headquartered in the Netherlands and has operations in multiple African countries. To find out more about EASE, visit https://www.easeglobal.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250423749021/en/

Contacts

Media Contacts:
EASE Holdings
Cydney Bell
press@easeglobal.com
+254 791 854841

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LambdaTest Integrates with Assembla to Streamline Bug Tracking for Development Teams3.6.2025 18:00:00 EEST | Press release

LambdaTest, a unified agentic AI and cloud engineering platform, has announced its partnership with Assembla, a robust cloud-based platform for version control and project management. This collaboration enables software development teams to streamline their bug tracking processes and improve overall productivity. LambdaTest offers developers an exhaustive list of cloud-based testing solutions, including cross-browser compatibility testing, Web and App automation testing, and Real Device testing. Assembla users can now easily integrate with the LambdaTest platform to seamlessly mark bugs with detailed screenshots and assign them to team members. "This integration between LambdaTest and Assembla allows development teams to optimize their testing and bug tracking processes," said Mayank Bhola, Co-Founder and Head of Product at LambdaTest. "By connecting these platforms, teams can maintain uninterrupted workflow while ensuring thorough documentation and tracking of issues discovered during

The Future of AI in the AEC Industry Unveiled at BST Global’s 2025 AI Summit3.6.2025 17:41:00 EEST | Press release

BST Global, the leading provider of AI-powered project intelligence™ solutions for the AEC industry, hosted its second annual AI Summit, May 6–8, 2025, in Palm Beach, FL. The premier event brought together 12 thought leaders from some of the world’s most influential firms, including Arcadis, Arup, AtkinsRéalis, Gensler, GHD, Jacobs, Mott MacDonald, NVIDIA, Parsons, Stantec, and WSP to share insights on how AI is reshaping the future of the AEC industry. Attendees as well as the broader AEC community praised the 2025 AI Summit for its timely content and line-up of industry trailblazers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603538561/en/ BST Global Chief Executive Officer Javier A. Baldor officially kicks off the AI Summit’s first full day of sessions by presenting his perspective on the driving forces impacting the AEC industry and the world at large. He shares three key ways AI and big data will transform nearly

Incyte Announces Multiple Presentations, Including New Late-Breaking Data for its mutCALR-Directed Monoclonal Antibody (INCA033989), Accepted for Presentation at EHA 20253.6.2025 17:30:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced that data from numerous programs in its hematology/oncology portfolio will be presented at the 2025 European Hematology Association (EHA) congress, held June 12 – 15, 2025, in Milan. "We're looking forward to presenting new data from across our hematology/oncology portfolio at the 2025 EHA Congress, including late-breaking data for our first in class, mutCALR-directed monoclonal antibody, INCA033989,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “We believe the data that will be presented at the late-breaking session demonstrate the impact of the novel mechanism of action of this monoclonal antibody against mutCALR-driven essential thrombocythemia (ET), and support its potential to be a disease modifying agent and thus transform the treatment of patients with myeloproliferative neoplasms (MPNs) like essential thrombocythemia (ET)." Key Incyte abstracts accepted for presentation at EHA include: Late-Breaking Or

European Commission Approves ADCETRIS ® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD3.6.2025 17:12:00 EEST | Press release

Takeda(TSE:4502/NYSE:TAK) today announced that the European Commission (EC) approved ADCETRIS® (brentuximab vedotin) in combination with etoposide, cyclophosphamide, doxorubicin, dacarbazine and dexamethasone (ECADD) – a chemotherapy regimen – in adult patients with newly diagnosed Stage IIb with risk factors/III/IV Hodgkin lymphoma. The decision follows a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) on April 25, 2025. The approval for this ADCETRIS-based combination regimen, known as BrECADD, in frontline Hodgkin lymphoma is based on the results of the randomized Phase 3 HD21 trial. The study met its co-primary safety and efficacy endpoints, with BrECADD demonstrating significantly superior safety as assessed by treatment-related morbidity (TRMB) and non-inferior progression-free survival (PFS) in comparison to escalated doses of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone (eBEACOPP), a standard of ca

Automotive Industry Shifts Gears As Talent and Technology Take Center Stage3.6.2025 17:00:00 EEST | Press release

Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced the results of the 10th annual “State of Smart Manufacturing Report: Automotive Edition.” The global study encompasses the responses of 130 leaders across automotive and tire manufacturers, original equipment manufacturers, engineering procurement companies and systems integrators across 15 countries, revealing a sector rapidly embracing change to stay competitive. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603797393/en/ Rockwell Automation report shows manufacturers are leaning into AI, upskilling and innovation to overcome workforce and operational challenges. Workforce pressures have emerged as the most urgent challenge for automotive companies, signaling a significant shift from last year’s findings. At the same time, concerns around cybersecurity have declined, suggesti

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye